COVID-19 Diagnostics Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027
Global COVID-19 Diagnostics market is
estimated to reach $9.4 billion in 2027, by growing at a CAGR of -21.6% during
the forecast period (2021-2027). The global COVID-19 diagnostic market is
expected to grow significantly owing to the increasing number of COVID-19
cases, cohesive government initiatives and investment, development of new
diagnostic tests, and the regional government approvals. A massive surge in
testing will be witnessed in all the affected economies around the globe.
Moreover, an increment in testing will be witnessed in emerging economies such
as India, China, Brazil, among others, as compared to the 2020 YoY level.
However, a downfall is expected to be witnessed in 2020 in developed economies,
including the US, Germany, UK, France, Spain, Italy, Canada, among others. It
is due to the control on the COVID-19 cases by these economies, rapid
manufacturing, and distribution of the vaccine among its population, and
decrement in the overall cost of diagnostic tests all across the globe.
(Get 15% Discount on Buying this Report)
A full report of COVID-19 Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/covid-19-diagnostics-market
Expansion
of COVID-19 testing facilities
In terms of increasing the accessibility
of testing at several locations, the government of the countries is
particularly focusing on the expansion of their testing centers. Apart from
aiming to increase access to testing among the population, this initiative aims
to prevent further spread of novel coronavirus. For instance, on 24th April
2020, as part of the UK government initiative to expand testing for thousands
of more key workers at the National Health Service (NHS) and others, the
COVID-19 mobile testing facility was opened on the Isle of Wight.
To learn more about this report request a sample
copy @ https://www.omrglobal.com/request-sample/covid-19-diagnostics-market
This facility has been arranged through
close collaboration working with the Local Resilience Forum (LRF) to support
key workers who have started to experience symptoms of COVID-19 in the past
five days, to access local facilities, instead of having to travel to the
mainland. The free testing facility is also provided by the government to
encourage suspected people to know the status of their condition. On 30th June
2020, Bavaria (German state) declared that it is offering free of charge
COVID-19 tests to all its residents. Under the rules, free tests are available
in the country for people with symptoms including fever and the country’s 16
states performed frequent tests among high-risk groups such as hospitals,
retirement homes, and daycare centers.
Scope
of the Global COVID-19 Diagnostics Market
Market
Coverage
·
Market number available - 2021-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered- By Type, Technology and End
user
·
Regions Covered- North America (US and Canada),
Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific
(China, Japan, India, and Rest of Asia-Pacific), and Rest of World (Middle East
and Africa, Latin America)
·
Competitive Landscape- Abbott Laboratories Inc.,
biomérieux SA, Cellex Inc., Cepheid Inc., F. Hoffman-La Roche AG, Laboratory
Corp. of America Holdings, Luminex Corp., PerkinElmer Inc., Mylab Discovery
Solutions Pvt Ltd., Thermo Fisher Scientific Inc.
Recent
Strategic Initiatives in the Global COVID-19 Diagnostics Market
·
In the first week of August 2020, Abbott
reported that it has shipped 6.5 million of its rapid ID NOW coronavirus tests,
5.6 million of its molecular lab tests (m2000 and Alinity m), and more than 13
million ARCHITECT and Alinityi COVID-19 antibody tests, which were launched in
mid-April 2020, as its third COVID-19 tests, to customers across the US.
·
In April 2020, ADT Biotech received a license
for the LyteStar 2019-nCoV RT-PCR Kit and the LyteStar SARS-CoV-2 RT-PCR Kit S
for import in India after receiving validation by the ICMR (Indian Council of
Medical Research), Ministry of Health & Family Welfare, India, and CDSCO
(Central Drugs Standard Control Organisation).
Global
COVID-19 Diagnostics Market-Segmentation
By
Technology
·
Polymerase Chain Reaction (PCR)
·
Antibody or Enzyme-Linked Immunosorbent Assay
(ELISA)
·
Serology
By
Type
·
Instruments
·
Reagents & Kits
By End user
·
Hospitals
·
Diagnostic Centers & Urgent Care Clinics
·
Research Labs
For more customized data, request for report
customization @ https://www.omrglobal.com/report-customization/covid-19-diagnostics-market
Global
COVID-19 Diagnostics Market– Segment by Country
North America
·
US
·
Canada
Europe
·
UK
·
Germany
·
France
·
Italy
·
Spain
·
Rest of Europe
Asia-Pacific
·
China
·
Japan
·
India
·
Rest of
Asia-Pacific
Rest of the World
Company
Profiles
·
Abbott Laboratories Inc.
·
biomérieux SA
·
Cellex Inc.
·
Cepheid Inc.
·
F. Hoffman-La Roche AG
·
Laboratory Corp. of America Holdings
·
Luminex Corp.
·
PerkinElmer Inc.
·
Mylab Discovery Solutions Pvt Ltd.
·
Thermo Fisher Scientific Inc
·
Quidel Corp.
·
Seegene Inc.
·
SureScreen Diagnostics Ltd.
·
Veredus Laboratories
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About
Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For
More Information, Visit Orion Market
Research
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
0 Comments